News Release

 

Back
 

AmerisourceBergen Completes Purchase of AutoMed Technologies, Inc.; Largest Pharmaceutical Distributor Adds Automated Pharmacy Dispensing Capability

07/17/02
VALLEY FORGE, Pa., Jul 17, 2002 (BUSINESS WIRE) -- AmerisourceBergen Corporation (NYSE:ABC), the largest pharmaceutical services company in the U.S. dedicated solely to the pharmaceutical supply chain, today announced the completion of its purchase of AutoMed Technologies, Inc., a leading provider of automated pharmacy dispensing equipment, for approximately $120 million in cash. The transaction also includes incentive payments based on AutoMed achieving earnings targets over the next two-and-a-half years. AutoMed, which is headquartered in the Chicago area and privately held, anticipates revenues of over $60 million in calendar year 2002. AmerisourceBergen expects the purchase to be slightly accretive immediately.

    About AmerisourceBergen
AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, alternate care and mail order facilities, independent community pharmacies, and regional chain pharmacies. The Company is also a leader in the institutional pharmacy marketplace. With more than $39 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people serving over 25,000 customers.

    About AutoMed
Established in 1994, AutoMed Technologies, Inc. is a privately held corporation supporting pharmacy operations worldwide with the most advanced pharmacy automation prescription fulfillment and distribution systems designed to significantly increase the efficiency of any pharmacy. AutoMed is the only company serving every segment of the pharmacy market, including retail drug stores, hospitals, long-term care facilities, mail order and e-commerce. Forward-Looking Statements

This press release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The forward-looking statements herein include statements addressing future financial and operating results of AmerisourceBergen and the benefits and other aspects of the merger between Amerisource Health Corporation and Bergen Brunswig Corporation.

The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: the risk that the businesses of AmeriSource and Bergen Brunswig will not be integrated successfully; failure to obtain and retain expected synergies; and other economic, business, competitive and/or regulatory factors affecting the business of AmerisourceBergen generally.

More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for fiscal 2001, Form 10-Q for the first and second quarters of fiscal 2002, and AmeriSource's and Bergen's joint proxy statement-prospectus dated August 1, 2001.

AmerisourceBergen, AmeriSource and Bergen Brunswig are under no obligation to (and expressly disclaim any such obligation to) update or alter their forward-looking statements whether as a result of new information, future events or otherwise.

    (c) Copyright 2002 AmerisourceBergen Corporation.
CONTACT:          AmerisourceBergen
                  Michael N. Kilpatric, 610/727-7118
                  mkilpatric@amerisource.com

Corporate Overview

AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel..

Learn More